methylprednisolone will decrease the extent or result of diazepam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.Coadministration of encorafenib with delicate CYP3A4 substrates might bring about enhanced toxicity or decreased efficacy of those brokers.Mainly because diazepam and its metabolites can be present in human